Laxmi India Finance Ltd has raised over Rs 75 crore from anchor investors ahead of its initial public offering (IPO). The NBFC player has allotted 47.79 lakh equity shares to 11 funds at Rs 158 apiece.
Check out the latest stock picks and analyst calls from top brokerages on Indian stocks like IndusInd Bank, Torrent Pharma, GAIL, and more.
Citi Research has increased the price target for Torrent Pharmaceuticals Ltd. to Rs 4,380 from Rs 4,000, citing a healthy and in-line quarter and solid traction across the markets. The brokerage maintains a ‘buy’ rating for the firm.
The Indian rupee has weakened to 86.83 against the US dollar, marking its lowest level since June 19. What’s driving the slide and what does it mean for Indian investors and traders?
Discover the top 5 Indian stocks to buy, as recommended by analysts from IDBI Cap, Kushbohra.com, and JM Financial. Learn about Cartrade Tech, Cipla, Vijay Diagnostic Centre, Fortis Healthcare, and Dabur India.
Shares of Torrent Pharmaceutical Ltd. surged to a record high after the company reported a 20% jump in its quarterly profit and Citi Research increased its price target.
Mazagon Dock Shipbuilders’ share price slumps to a three-month low as the company misses net profit estimates. Dive into the Q1 earnings report and explore the market implications.
NTPC Green Energy shares experienced a sharp intraday fluctuation after the release of its first-quarter earnings for FY26. The company’s robust set of numbers led to an initial rise of 2.35%, but later pared gains to trade 0.40% lower.
Ajanta Pharma Ltd.’s Q1 FY26 revenue surged 13.8% YoY and 11.3% QoQ, driven by strong growth in North America and India branded formulation. Systematix maintains a ‘Buy’ rating with a target price of Rs 3,293.
Amarendu Prakash, chairman and managing director of SAIL, highlights that the quarterly dip was on the back of planned maintenance activities at plants, calling it a one-time accounting hit. He remains confident of achieving 8% growth for financial year 2026 over 2025.